Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Neuro-Oncology|May 1, 2020
A retrospective, quantitative assessment of disease burden in patients with leptomeningeal metastases from non-small-cell lung cancerKathryn S Nevel, Natalie DiStefano, Xuling Lin, et al.
Journal of Neuro-Oncology|November 6, 2013
Temporal relationship of post-operative radiotherapy with temozolomide and oncologic outcome for glioblastomaDaniel E Spratt, Michael Folkert, Zachary S Zumsteg, et al.
Oncotarget|November 19, 2016
Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignanciesParisa Momtaz, Elena Pentsova, Omar Abdel-Wahab, et al.
Leukemia & Lymphoma|June 15, 2023
Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System LymphomaChristian Grommes, Elena Pentsova, Lauren R Schaff, et al.
Journal of Pain and Symptom Management|November 5, 2016
Frequency and Predictors of Acute Hospitalization Before Death in Patients With GlioblastomaEli L Diamond, Katherine S Panageas, Alexis Dallara, et al.
Journal of Neuro-Oncology|April 30, 2015
Radiotherapy and temozolomide for anaplastic astrocytic gliomasLakshmi Nayak, Katherine S Panageas, Anne S Reiner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2019
Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System MetastasesAki Morikawa, Elisa de Stanchina, Elena Pentsova, et al.
Neuro-Oncology|August 29, 2024
NANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastasesEmilie Le Rhun, Lakshmi Nayak, Mary Jane Lim-Fat, et al.
Journal of Neuro-Oncology|February 3, 2022
Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastasesMaria Diaz, Priya Singh, Ivan S Kotchetkov, et al.
Neurology|August 10, 2022
Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case SeriesLauren R Schaff, Marina Kushnirsky, Andrew L Lin, et al.
Pageof 6